Search

everythinglearnresearchcommunity

for

Search:↓

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Cavity macrophages gather on organ surfaces but don't really invade or help repair the organs after injury.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Daily intake of 0.5 or 5 mg cobalt ferrite nanoparticles can harm lungs through oxidative and inflammatory stress.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Dermoscopy now helps diagnose various skin, hair, and nail issues, improving patient care and treatment understanding.

Acne lesions start with changes in hair follicles and increase in inflammation, suggesting a cycle that could affect treatment strategies.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.